Diagnosis, Treatment, and Research Status of Rare Diseases Related to Birth Defects

Overview

Journal Intractable Rare Dis Res

Date 2023 Sep 4

PMID 37662624

Authors

Hongjuan Zhao

Chen Du

Guang Yang

Yu Wang

Affiliations

Soon will be listed here.

Abstract

Rare diseases are diseases that occur at low prevalence, and most of them are chronic and serious diseases that are often life-threatening. Currently, there is no unified definition for rare diseases. The diagnosis, treatment, and research of rare diseases have become the focus of medicine and biopharmacology, as well as the breakthrough point of clinical and basic research. Birth defects are the hard-hit area of rare diseases and the frontiers of its research. Since most of these defects have a genetic basis, early screening and diagnosis have important scientific value and social significance for the prevention and control of such diseases. At present, there is no effective treatment for most rare diseases, but progress in prenatal diagnosis and screening can prevent the occurrence of diseases and help prevent and treat rare diseases. This article discusses the progress in genetic-related birth defects and rare diseases.

References

Gurovich Y, Hanani Y, Bar O, Nadav G, Fleischer N, Gelbman D . Identifying facial phenotypes of genetic disorders using deep learning. Nat Med. 2019; 25(1):60-64. DOI: 10.1038/s41591-018-0279-0. View

Chen B, Du Y, Zhu H, Sun M, Wang C, Cheng Y . Maternal inheritance of glucose intolerance via oocyte TET3 insufficiency. Nature. 2022; 605(7911):761-766. DOI: 10.1038/s41586-022-04756-4. View

Merker J, Wenger A, Sneddon T, Grove M, Zappala Z, Fresard L . Long-read genome sequencing identifies causal structural variation in a Mendelian disease. Genet Med. 2017; 20(1):159-163. PMC: 5741540. DOI: 10.1038/gim.2017.86. View

Claeys L, Zhytnik L, Wisse L, van Essen H, Eekhoff E, Pals G . Exploration of the skeletal phenotype of the mouse model for haploinsufficient osteogenesis imperfecta type 1. Front Endocrinol (Lausanne). 2023; 14:1145125. PMC: 10031054. DOI: 10.3389/fendo.2023.1145125. View

Chawla B, Hasan F, Azad R, Seth R, Upadhyay A, Pathy S . Clinical presentation and survival of retinoblastoma in Indian children. Br J Ophthalmol. 2015; 100(2):172-8. DOI: 10.1136/bjophthalmol-2015-306672. View

Cornelissen M, den Ottelander B, Rizopoulos D, van der Hulst R, van der Molen A, van der Horst C . Increase of prevalence of craniosynostosis. J Craniomaxillofac Surg. 2016; 44(9):1273-9. DOI: 10.1016/j.jcms.2016.07.007. View

Tingaud-Sequeira A, Trimouille A, Marlin S, Lopez E, Berenguer M, Gherbi S . Functional and genetic analyses of ZYG11B provide evidences for its involvement in OAVS. Mol Genet Genomic Med. 2020; 8(10):e1375. PMC: 7549578. DOI: 10.1002/mgg3.1375. View

Krug P, Moriniere V, Marlin S, Koubi V, Gabriel H, Colin E . Mutation screening of the EYA1, SIX1, and SIX5 genes in a large cohort of patients harboring branchio-oto-renal syndrome calls into question the pathogenic role of SIX5 mutations. Hum Mutat. 2011; 32(2):183-90. DOI: 10.1002/humu.21402. View

Cummings B, Marshall J, Tukiainen T, Lek M, Donkervoort S, Foley A . Improving genetic diagnosis in Mendelian disease with transcriptome sequencing. Sci Transl Med. 2017; 9(386). PMC: 5548421. DOI: 10.1126/scitranslmed.aal5209. View

10.

Lopez E, Berenguer M, Tingaud-Sequeira A, Marlin S, Toutain A, Denoyelle F . Mutations in , encoding the myelin transcription factor 1, are a rare cause of OAVS. J Med Genet. 2016; 53(11):752-760. DOI: 10.1136/jmedgenet-2016-103774. View

11.

Yan L, Yang M, Guo H, Yang L, Wu J, Li R . Single-cell RNA-Seq profiling of human preimplantation embryos and embryonic stem cells. Nat Struct Mol Biol. 2013; 20(9):1131-9. DOI: 10.1038/nsmb.2660. View

12.

Xiang L, Tao J, Deng K, Li X, Li Q, Yuan X . Phenylketonuria incidence in China between 2013 and 2017 based on data from the Chinese newborn screening information system: a descriptive study. BMJ Open. 2019; 9(8):e031474. PMC: 6707664. DOI: 10.1136/bmjopen-2019-031474. View

13.

Guo L, Wang Q, Weng L, Hauser L, Strawser C, Rocha A . Liquid Chromatography-High Resolution Mass Spectrometry Analysis of Platelet Frataxin as a Protein Biomarker for the Rare Disease Friedreich's Ataxia. Anal Chem. 2017; 90(3):2216-2223. PMC: 5817373. DOI: 10.1021/acs.analchem.7b04590. View

14.

Atanasova V, Russell R, Webster T, Cao Q, Agarwal P, Lim Y . Thrombospondin-1 Is a Major Activator of TGF-β Signaling in Recessive Dystrophic Epidermolysis Bullosa Fibroblasts. J Invest Dermatol. 2019; 139(7):1497-1505.e5. DOI: 10.1016/j.jid.2019.01.011. View

15.

Hoornaert K, Vereecke I, Dewinter C, Rosenberg T, Beemer F, Leroy J . Stickler syndrome caused by COL2A1 mutations: genotype-phenotype correlation in a series of 100 patients. Eur J Hum Genet. 2010; 18(8):872-80. PMC: 2987380. DOI: 10.1038/ejhg.2010.23. View

16.

Abulezz T, Allam K, Wan D, Lee J, Kawamoto H . Saethre-Chotzen Syndrome: A Report of 7 Patients and Review of the Literature. Ann Plast Surg. 2020; 85(3):251-255. DOI: 10.1097/SAP.0000000000002391. View

17.

Kocher T, Koller U . Advances in gene editing strategies for epidermolysis bullosa. Prog Mol Biol Transl Sci. 2021; 182:81-109. DOI: 10.1016/bs.pmbts.2020.12.007. View

18.

Gaucher S, Lwin S, Titeux M, Abdul-Wahab A, Pironon N, Izmiryan A . EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa. Br J Dermatol. 2019; 182(3):794-797. DOI: 10.1111/bjd.18559. View

19.

Monaghan K, Leach N, Pekarek D, Prasad P, Rose N . The use of fetal exome sequencing in prenatal diagnosis: a points to consider document of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2020; 22(4):675-680. DOI: 10.1038/s41436-019-0731-7. View

20.

Kwong A, Cogan J, Hou Y, Antaya R, Hao M, Kim G . Gentamicin Induces Laminin 332 and Improves Wound Healing in Junctional Epidermolysis Bullosa Patients with Nonsense Mutations. Mol Ther. 2020; 28(5):1327-1338. PMC: 7210719. DOI: 10.1016/j.ymthe.2020.03.006. View